Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Elevated Risk of Intrahepatic Cholestasis of Pregnancy in Systemic Lupus Erythematosus Patients Treated with Azathioprine

  • By

  • Reem Farhat

  • Maria del Carmen Zamora-Medina

  • Sang-Cheol Bae

  • Megan R. W. Barber

  • Ann E. Clarke

  • Paul R. Fortin

  • Zahi Touma

  • Carl A. Laskin

  • Isabelle Malhamé

  • Giada Sebastiani

  • Christine Peschken

  • Manuel F. Ugarte-Gil

  • Alexandra Legge

  • Sasha Bernatsky

  • Évelyne Vinet

  • May 14, 2026

Share

Original Source(s)

Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine

  • by Reem Farhat, Maria del Carmen Zamora-Medina, Sang-Cheol Bae, Megan R. W. Barber, Ann E. Clarke, Paul R. Fortin, Zahi Touma, Carl A. Laskin, Isabelle Malhamé, Giada Sebastiani, Christine Peschken, Manuel F. Ugarte-Gil, Alexandra Legge, Sasha Bernatsky, Évelyne Vinet

  • May 14, 2026

Related Content

Maternal Influenza Infection During Pregnancy and Neuropsychiatric Disorders in Offspring

HHS Launches Newborn Essentials Support Toolkit Program to Support Mothers and Babies

Pregnancy After CAR T Shows Early Promise

No autoimmune disease flares occurred across 14 pregnancies after CAR T-cell therapy, with 8 healthy babies born and 5 pregnancies ongoing.